PHM Protech Home Medical Corp

Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on
rolling-up annuity-based healthcare service companies in the US and Canada,
today provided an update on its large and growing pipeline of potential
acquisition targets. In preparation for these potential upcoming acquisitions,
PHM also announced that its CEO, Bob Kusher, has decided to create a Board of
Advisors to offer additional expertise about integrating acquisitions and
increasing revenue through cross selling efforts based on their extensive
knowledge of the field. 


Acquisition Pipeline - 12 active acquisition candidates

PHM is addressing a large and fragmented market of small, profitable businesses
providing healthcare services to chronically ill patients. PHM began to create
the pipeline of potential acquisition targets in June 2013 in order to expand
its service offerings as well as total patients serviced. 


Offers Made to 4 Companies

As of the date of this announcement, PHM had made initial non-binding offers to
acquire four separate businesses. The four acquisition targets have a combined
trailing 12-month EBITDA of $4.5 million, each ranging from $750,000 to $1.9m in
EBTIDA. PHM will perform additional due diligence on these companies before
executing a Letter of Intent (LOI). Assuming these acquisition targets pass the
due diligence process and a LOI is executed, PHM would next sign a binding
purchase agreement and close the acquisitions. PHM expects that it can close all
four acquisitions with its current balance sheet. Depending upon due diligence,
and other intervening opportunities from its growing pipeline that may be
presented, PHM may move forward more or less aggressively with these targets.


Initial Due Diligence with 8 Additional Companies

PHM has identified and is in active discussions with eight additional
acquisition target companies that it has established as qualified and motivated
to sell. These companies are in the initial due diligence process where PHM's
M&A team is determining historical financial information and gathering general
market intelligence about the target and their markets. 


PHM continues to build its deal pipeline on a weekly basis through an assortment
of finders and market participants. 


"I am excited about our future acquisition prospects," said Mr. Bob Kusher, CEO
of PHM. "I have decided to recruit an experienced board to advise me on
integrating each acquisition, with a particular focus on maximizing revenue per
patient served. I believe this cross sell strategy works because of our
high-touch service model, we believe PHM is the best-positioned company in the
market to provide more and more services for each of our newly acquired
patients. With a seemingly unlimited amount of acquisition targets, I believe we
have a model for significant profit growth in the near term."


About PHM

PHM is a profitable and cash flow positive company servicing patients with
chronic heart disease and will act as a platform for acquisitions. PHM is
focused on a highly fragmented and developing market of small privately-held
companies servicing chronically ill patients with multiple disease states caused
mainly by age and obesity. Because of the new and highly fragmented nature of
the market, PHM is actively working to identify and evaluate profitable,
annuity-based companies to acquire their patient databases and technical
expertise at favorable prices. PHM's post acquisition organic growth strategy is
to increase annual revenue per patient by offering multiple services to the same
patient, consolidating the patient's services and making life easier for the
patient. The expected result is growing EPS with each acquisition and growing
revenue and profits from the cross selling efforts. 


Forward -Looking Statements 

Information in this news release that is not current or historical factual
information may constitute forward-looking information within the meaning of
securities laws. Implicit in this information, particularly in respect of the
future outlook of PHM and anticipated events or results, are assumptions based
on beliefs of PHM's senior management as well as information currently available
to it. While these assumptions were considered reasonable by PHM at the time of
preparation, they may prove to be incorrect. 


Readers are cautioned that actual results are subject to a number of risks and
uncertainties, including the availability of funds and resources to pursue
operations or acquisitions, decline of reimbursement rates, dependence on few
payors, possible new drug discoveries, a novel business model, dependence on key
suppliers, granting of permits and licenses in a highly regulated business,
competition, availability of qualified senior management, risks from change in
ownership or unfamiliarity with new markets, low profit market segments as well
as general economic, market and business conditions, and could differ materially
from what is currently expected. 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Patient Home Monitoring
Michael Dalsin
Chairman
(323) 253-3055

Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Sep 2024 to Oct 2024

Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Oct 2023 to Oct 2024